Stockreport

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF CUPERTINO, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical comp [Read more]